(19)
(11) EP 1 976 492 B8

(12) CORRECTED NEW EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B2)

(48) Corrigendum issued on:
04.07.2018 Bulletin 2018/27

(45) Date of publication and mentionof the opposition decision:
16.05.2018 Bulletin 2018/20

(45) Mention of the grant of the patent:
21.01.2015 Bulletin 2015/04

(21) Application number: 07717476.1

(22) Date of filing: 29.01.2007
(51) International Patent Classification (IPC): 
A61K 9/22(2006.01)
A61K 31/403(2006.01)
A61K 31/53(2006.01)
A61K 31/4178(2006.01)
A61K 31/519(2006.01)
(86) International application number:
PCT/US2007/061237
(87) International publication number:
WO 2007/090091 (09.08.2007 Gazette 2007/32)

(54)

DRUG DELIVERY SYSTEMS COMPRISING WEAKLY BASIC DRUGS AND ORGANIC ACIDS

WIRKSTOFFFREISETZUNGSSYSTEME MIT LEICHT BASISCHEN WIRKSTOFFEN UND ORGANISCHEN SÄUREN

SYSTÈME D'ADMINISTRATION DE MÉDICAMENTS COMPRENANT DES MÉDICAMENTS FAIBLEMENT BASIQUES ET DES ACIDES ORGANIQUES


(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

(30) Priority: 27.01.2006 US 762766 P

(43) Date of publication of application:
08.10.2008 Bulletin 2008/41

(60) Divisional application:
11001815.7 / 2387994

(73) Proprietor: Adare Pharmaceuticals, Inc.
Lawrenceville, NJ 08648 (US)

(72) Inventor:
  • VENKATESH, Gopi, M.
    Vandalia, OH 45377 (US)

(74) Representative: Cooley (UK) LLP 
Dashwood 69 Old Broad Street
London EC2M 1QS
London EC2M 1QS (GB)


(56) References cited: : 
EP-B1- 0 032 562
WO-A-2005/077341
WO-A1-2005/065726
US-A- 4 367 217
US-A- 5 320 853
US-A1- 2001 046 964
US-A1- 2003 170 304
US-A1- 2004 258 749
US-A1- 2005 238 717
US-B2- 6 627 223
WO-A-2004/096182
WO-A1-03/074032
WO-A2-2007/023329
US-A- 4 786 505
US-A- 6 015 577
US-A1- 2003 113 374
US-A1- 2004 019 096
US-A1- 2005 118 268
US-B1- 6 383 471
US-B2- 6 663 888
   
  • Streubel et al., Journal of controlled release 67, 2000, pages 101-110